ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,826Medicare Part D Prescriptions Filled, Including Refills

Rank: 314 out of 680

$409K Total Retail Price of All Prescriptions

Rank: 342 out of 680

382 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 382 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 7,216 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 420 397 1 5
LEVOTHYROXINE SODIUM 371 370 2 2
SIMVASTATIN 364 358 3 3
AMLODIPINE BESYLATE 274 252 4 1
ATORVASTATIN CALCIUM 221 212 5 11
HYDROCHLOROTHIAZIDE 183 181 6 9
ATENOLOL 171 159 7 19
METFORMIN HCL 165 150 8 8
FUROSEMIDE 147 123 9 6
SYNTHROID 136 130 10 38
OMEPRAZOLE 132 114 11 7
SERTRALINE HCL 124 110 12 28
LOSARTAN POTASSIUM 123 123 13 21
METFORMIN HCL ER 107 87 14 54
METOPROLOL SUCCINATE 102 100 15 13
HYDROCODONE-ACETAMINOPHEN 102 95 S3 15 4
GLYBURIDE 100 100 R 17 85
GABAPENTIN 95 78 18 15
NEXIUM 85 71 19 16
MELOXICAM 81 70 20 24
PRAVASTATIN SODIUM 80 75 21 10
LOSARTAN-HYDROCHLOROTHIAZIDE 77 77 22 51
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 63 23 37
ZOLPIDEM TARTRATE 73 69 24 17
PANTOPRAZOLE SODIUM 72 72 25 30
WARFARIN SODIUM 68 68 26 20
PAROXETINE HCL 67 67 27 76
POTASSIUM CHLORIDE 64 64 28 14
BENICAR HCT 63 63 29 150
ESCITALOPRAM OXALATE 59 55 30 45
LOVASTATIN 58 45 31 44
ALLOPURINOL 57 46 32 33
CITALOPRAM HBR 56 56 33 22
TRAMADOL HCL 54 51 34 18
BENAZEPRIL HCL 53 37 35 40
AZITHROMYCIN 51 47 36 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.